Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EB
- Chemical substanceL01EB03Afatinib
L01XE13
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 12 registrations
- Giotrif40 MG · Tablet · Boehringer Ingelheim (Canada) LTD Ltee
- Giotrif30 MG · Tablet · Boehringer Ingelheim (Canada) LTD Ltee
- Giotrif20 MG · Tablet · Boehringer Ingelheim (Canada) LTD Ltee
- Mar-Afatinib40 MG · Tablet · Marcan Pharmaceuticals INC
Spain
AEMPS · 4 registrations
At a glance
- ATC code
- L01EB03, L01XE13
- Registers
- 9
- Historical lists
- 2
- Registrations
- 39
- With their own page
- 27
- Companies
- 13
All medicines with Afatinib
Human medicines from every register that match Afatinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
39 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Mar-Afatinib | Canada | 30 MG | Tablet | Marketed | Marcan Pharmaceuticals INC |
| Mar-Afatinib | Canada | 20 MG | Tablet | Marketed | Marcan Pharmaceuticals INC |
| Mar-Afatinib | Canada | 40 MG | Tablet | Marketed | Marcan Pharmaceuticals INC |
| Sandoz Afatinib | Canada | 40 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Sandoz Afatinib | Canada | 30 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Sandoz Afatinib | Canada | 20 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Gilotrif | United States | 20MG BASE, 30MG BASE, 40MG BASE | tablet | Marketed | Boehringer Ingelheim |
| Giotrif | European Union | Authorised | Boehringer Ingelheim International GmbH | ||
| Giotrif 20 MG Comprimidos Recubiertos con Pelicula | Spain | 20 mg | comprimido recubierto con película | Marketed | Boehringer Ingelheim International Gmbh |
| Giotrif 30 MG Comprimidos Recubiertos con Pelicula | Spain | 30 mg | comprimido recubierto con película | Marketed | Boehringer Ingelheim International Gmbh |
| Giotrif 40 MG Comprimidos Recubiertos con Pelicula | Spain | 40 mg | comprimido recubierto con película | Marketed | Boehringer Ingelheim International Gmbh |
| Giotrif 20 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Boehringer Ingelheim International GmbH | |
| Giotrif 30 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Boehringer Ingelheim International GmbH | |
| Giotrif 40 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Boehringer Ingelheim International GmbH | |
| Giotrif 50 MG Comprimidos Recubiertos con Pelicula | Spain | 50 mg | comprimido recubierto con película | Authorised | Boehringer Ingelheim International Gmbh |
| Giotrif 50 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Boehringer Ingelheim International GmbH | |
| Giotrif | Canada | 40 MG | Tablet | Marketed | Boehringer Ingelheim (Canada) LTD Ltee |
| Giotrif | Canada | 20 MG | Tablet | Marketed | Boehringer Ingelheim (Canada) LTD Ltee |
| Giotrif | Canada | 30 MG | Tablet | Marketed | Boehringer Ingelheim (Canada) LTD Ltee |
| Giotrif | Brazil | Authorised | Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. | ||
| Giotrif Film-Coated Tablets 20MG | Singapore | 20.0000mg | tablet, film coated | Authorised | Boehringer Ingelheim Singapore Pte. LTD. |
| Giotrif Film-Coated Tablets 30MG | Singapore | 30.0000mg | tablet, film coated | Authorised | Boehringer Ingelheim Singapore Pte. LTD. |
| Giotrif Film-Coated Tablets 40MG | Singapore | 40.0000mg | tablet, film coated | Authorised | Boehringer Ingelheim Singapore Pte. LTD. |
| Giotrif® | Serbia | 20mg | film tableta | Authorised | Boehringer Ingelheim Serbia D.O.O. Beograd |
| Giotrif® | Serbia | 30mg | film tableta | Authorised | Boehringer Ingelheim Serbia D.O.O. Beograd |